David Alan Urbanek

David Alan Urbanek, listed as chief executive, appears in our data through filings on Elanco Animal Health Inc shares, published by SEC (Form 4). We count 31 filings; the first trade dates from 24 September 2018 and the latest from 2 March 2023.

No open-market sale appears; the market trades are 5 purchases worth €16k. No amount is published for 1 filing, which the totals therefore leave out. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 26 share grants.

The median purchase comes to €1,807. Of 4 purchases, 1 formed part of a group of insiders buying within 30 days of each other. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.

Most recently, on 6 March 2023, the filings show a share grant worth €151k in Elanco Animal Health Inc. The latest purchase dates back some time: it was published 2,546 days ago, on 20 November 2019. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.